公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2023 | Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months | TUNG-HUNG SU ; Chang, Shan-Han; CHI-LING CHEN ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology research : the official journal of the Japan Society of Hepatology | 1 | 0 | |
2020 | Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study | MENG-RUI LEE ; Huang H.-L; LUN-CHE CHEN ; HUNG-CHIH YANG ; JEN-CHUNG KO ; Cheng M.-H; Chong I.-W; LI-NA LEE ; JANN-YUAN WANG ; Dimopoulos G. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 20 | 19 | |
2023 | Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy | Lin, Meng-Ju; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; JYH-MING LIOU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; CHUN-MING HONG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 1 | |
2014 | Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications | Wu H.-L.; JIA-HORNG KAO ; Chen T.-C; Wu W.-H; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; DING-SHINN CHEN ; PEI-JER CHEN ; CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 28 | 24 | |
2022 | Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents | SHANG-CHIN HUANG ; Cheng, Pin-Nan; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of the Formosan Medical Association = Taiwan yi zhi | 8 | 11 | |
2021 | Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; Chen, Tony Hsiu Hsi ; PEI-JER CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 14 | 15 | |
2013 | Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Hsu C.-A; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 218 | 195 | |
2020 | Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis | TUNG-HUNG SU ; Peng C.-Y; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 10 | 8 | |
2022 | Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis | TUNG-HUNG SU ; Peng, Cheng-Yuan; Chang, Shan-Han; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 10 | 10 | |
2018 | Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B | Papatheodoridis G.V.; Manolakopoulos S; TUNG-HUNG SU ; Siakavellas S; CHUN-JEN LIU ; Kourikou A; HUNG-CHIH YANG ; JIA-HORNG KAO | Hepatology | 44 | 39 | |
2009 | Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation | HUNG-CHIH YANG ; Xing S; Shan L; O'Connell K; Dinoso J; Shen A; Zhou Y; Shrum C.K; Han Y; Liu J.O; Zhang H; Margolick J.B; Siliciano R.F. | Journal of Clinical Investigation | 222 | 209 | |
2019 | Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection | CHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; CHUN-MING HONG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 14 | 15 | |
2018 | Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection | CHEN-HUA LIU ; YIH-SHARNG CHEN ; SHOEI-SHEN WANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical Infectious Diseases | 26 | 21 | |
2015 | Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition | TUNG-HUNG SU ; Shiau C.-W; Jao P; CHEN-HUA LIU ; CHUN-JEN LIU ; Tai W.-T; YUNG-MING JENG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; HSIANG-PO HUANG ; Cheng H.-R; PEI-JER CHEN ; Chen K.-F; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 65 | 62 | |
2017 | Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis | TUNG-HUNG SU ; Shiau C.-W; Jao P; Yang N.-J; Tai W.-T; CHUN-JEN LIU ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHEN-HUA LIU ; KAI-WEN HUANG ; Hu T.-C; Huang Y.-J; YAO-MING WU ; Chen L.-J; PEI-JER CHEN ; DING-SHINN CHEN ; Chen K.-F; JIA-HORNG KAO | Scientific Reports | 11 | 11 | |
2012 | Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation | Shan L; Deng K; Shroff N.S; Durand C.M; Rabi S.A; HUNG-CHIH YANG ; Zhang H; Margolick J.B; Blankson J.N; Siliciano R.F. | Immunity | 605 | 589 | |
2013 | Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up | Yu M.-L.; Lee C.-M; CHI-LING CHEN ; Chuang W.-L; Lu S.-N; CHEN-HUA LIU ; Wu S.-S; Liao L.-Y; Kuo H.-T; Chao Y.-C; Tung S.-Y; Yang S.-S; JIA-HORNG KAO ; Su W.-W; Lin C.-L; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Hepatology | 65 | 59 | |
2020 | Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943-2020) | HUNG-CHIH YANG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 3 | 2 | |
2017 | Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection | Shan L; Deng K; Gao H; Xing S; Capoferri A.A; Durand C.M; Rabi S.A; Laird G.M; Kim M; Hosmane N.N; HUNG-CHIH YANG ; Zhang H; Margolick J.B; Li L; Cai W; Ke R; Flavell R.A; Siliciano J.D; Siliciano R.F. | Immunity | 127 | 118 | |
2008 | Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor | Bailey J.R; O'Connell K; HUNG-CHIH YANG ; Han Y; Xu J; Jilek B; Williams T.M; Ray S.C; Siliciano R.F; Blankson J.N. | Journal of Virology | 89 | 86 |